Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 33,050 shares at $102.35 ($3.4M) on 2023-02-07, disclosed to the SEC on 2023-02-08.
Seasonal sale ($3.4M) by Chief Medical Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.80 | 1,121 | $119K | 3.5% |
| 2 | $105.80 | 1,121 | $119K | 3.5% |
| 3 | $102.35 | 1,623 | $166K | 4.9% |
| 4 | $102.35 | 1,623 | $166K | 4.9% |
| 5 | $102.41 | 12,801 | $1.3M | 38.6% |
| 6 | $102.41 | 12,801 |
| $1.3M |
| 38.6% |
| 7 | $104.16 | 980 | $102K | 3.0% |
| 8 | $104.16 | 980 | $102K | 3.0% |
| Total | $102.74 avg | 33,050 | $3.4M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |